1,856
Views
1
CrossRef citations to date
0
Altmetric
Bioanalytical Challenge

Regen-Cov® Antibody Cocktail Bioanalytical Strategy: Comparison of Lc-Mrm-Ms and Immunoassay Methods for Drug Quantification

, , , , , , , , , , , , , & show all
Pages 1827-1836 | Received 02 Sep 2021, Accepted 19 Oct 2021, Published online: 08 Nov 2021

References

  • Zhu N , ZhangD, WangWet al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med.382(8), 727–733 (2020).
  • Baum A , FultonBO, WlogaEet al. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science369(6506), 1014–1018 (2020).
  • Hansen J , BaumA, PascalKEet al. Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science369(6506), 1010–1014 (2020).
  • Fact Sheet for Health Care Providers Emergency Use Authorization (EUA) OF REGEN-COV (casirivimab and imdevimab). US FDA (2021).
  • Weinreich DM , SivapalasingamS, NortonTet al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N. Engl. J. Med.384(3), 238–251 (2021).
  • Zhong X , NayakS, GuoLet al. Liquid chromatography-multiple reaction monitoring-mass spectrometry assay for quantitative measurement of therapeutic antibody cocktail REGEN-COV concentrations in COVID-19 patient serum. Anal. Chem.93(38), 12889–12898 (2021).
  • O'Brien MP , Forleo-NetoE, SarkarNet al. Subcutaneous REGEN-COV antibody combination in early SARS-CoV-2 infection. medRxiv10.1101/2021.06.14.21258569 (2021).
  • O'Brien MP , Forleo-NetoE, MusserBJet al. Subcutaneous REGEN-COV antibody combination to prevent Covid-19. N. Engl. J. Med.385(13), 1184–1195 (2021).
  • Weinreich DM , SivapalasingamS, NortonTet al. REGEN-COV antibody combination and outcomes in outpatients with Covid-19. N. Engl. J. Med.10.1056/NEJMoa2108163 (2021).
  • Giavarina D . Understanding Bland Altman analysis. Biochem Med (Zagreb)25(2), 141–151 (2015).
  • Bioanalytical Method Validation Guidance for Industry. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), CfVMC (2018).
  • Booth B , StevensonL, PillutlaRet al. 2019 White Paper On Recent Issues in Bioanalysis: FDA BMV Guidance, ICH M10 BMV Guideline and Regulatory Inputs (Part 2 - Recommendations on 2018 FDA BMV Guidance, 2019 ICH M10 BMV Draft Guideline and Regulatory Agencies' Input on Bioanalysis, Biomarkers and Immunogenicity). Bioanalysis11(23), 2099–2132 (2019).
  • Wickham H . ggplot2: Elegant Graphics for Data Analysis. Springer International Publishing, NY, USA (2016).
  • Motulsky HJ , BrownRE. Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate. BMC Bioinformat.7, 123 (2006).
  • Altman DG , BlandJM. Measurement in medicine: the analysis of method comparison studies. J. Royal Statistical Soc.32(3), 307–317 (1983).
  • Papadimitriou A , BansalS, HeinrichJ, StaackRF. Can LC-MS/MS and ligand-binding assays live in harmony for large-molecule bioanalysis?Bioanalysis6(13), 1735–1737 (2014).
  • Schick E , StaackRF, HaakMet al. Validation of a ligand-binding assay for active protein drug quantification following the ‘free analyte QC concept’. Bioanalysis8(24), 2537–2549 (2016).
  • Staack RF , JordanG, ViertM, SchaferM, PapadimitriouA, HeinrichJ. Quantification of a bifunctional drug in the presence of an immune response: a ligand-binding assay specific for ‘active’ drug. Bioanalysis7(24), 3097–3106 (2015).
  • Report on the Deliberation Results and Report on Special Approval for Emergency: ronapreve. Japan Pharmaceuticals and Medical Devices Agency Pharmaceutical Evaluation Division, PSaEHBMoH, Labour and Welfare (2021).
  • Yuan M , IsmaielOA, MylottWRJ. Hybrid ligand binding immunoaffinity-liquid chromatography/mass spectrometry for biotherapeutics and biomarker quantitation: how to develop a hybrid LBA-LC-MS/MS method for a protein?Rev. Separation Sci.1(1), 47–55 (2019).
  • Copin R , BaumA, WlogaEet al. The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies. Cell184(15), 3949–3961e3911 (2021).
  • Liu Y , LiuL, YuNet al. Immunoaffinity LC-MS/MS is more suitable than ELISA to quantify a PEGylated molecule in cynomolgus monkey serum. Bioanalysis12(15), 1061–1069 (2020).
  • Huang X , XuX, PartridgeMAet al. Isotyping and semi-quantitation of monkey antiidiotype antibodies by immunocapture liquid chromatography-mass spectrometry. AAPS J.23(1), 16 (2021).
  • Neubert H , AlleySC, LeeAet al. 2020 White Paper on Recent Issues in Bioanalysis: BMV of Hybrid Assays, Acoustic MS, HRMS, Data Integrity, Endogenous Compounds, Microsampling and Microbiome (Part 1 – Recommendations on Industry/Regulators Consensus on BMV of Biotherapeutics by LCMS, Advanced Application in Hybrid Assays, Regulatory Challenges in Mass Spec, Innovation in Small Molecules, Peptides and Oligos). Bioanalysis.13(4), 203–238 (2021).
  • Wang SJ , WuST, GokemeijerJet al. Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of antiidiotype antibodies. Anal Bioanal Chem.402(3), 1229–1239 (2012).
  • Wang J , GuH, LiuAet al. Antibody-drug conjugate bioanalysis using LB-LC-MS/MS hybrid assays: strategies, methodology and correlation to ligand-binding assays. Bioanalysis.8(13), 1383–1401 (2016).